Srikalahasthi Pipes Ltd is getting merged with Electrosteel Castings Limited and Electrosteel numbers do not fit my rules. The record date for the purpose of Merger/HiveOff is 14-Jan-2022. I am planning to sell it at ₹204.5 and bought it for ₹145 on 2nd Feb 2021.
5yr Average Return on Equity is 1.07%
Debt to Equity (x) is 0.77
Earnings growth is uneven, the company did not earn profit in 2021.
Sold Sripipes @204.5 on Jan 12th, 2022.
Reasons for buying:
Buy PE was reasonable at 16.46 and above 10 years PE median of 13.98.
5-year earnings average is 91.72%, earnings are lackluster from 2012 and 10-Year average revenue growth is 12.42%.
Return on equity is excellent at 26.01% but the 5-year average is 27.42%.
The market cap of the company is ₹289.13cr.
The debt of the company is ₹0cr with ₹42.97cr in cash.
Buy date: 30-Nov-2021
Qty: 14 Buy Price: ₹695 Buy EPS: 42.22 Buy PE: 16.46
I will be adding if the price drops because the earnings average is above 15% and the 5-year ROE average is above 15%.
Sold date: 05-Apr-2022
Qty: 14 Buy Price: ₹1296.6 Buy EPS: 43.22 Buy PE: 30
PE is 30 so sold it.
Avantel Ltd is engaged in the business of manufacturing telecom products and provides related customer support services. It caters to both domestic and international markets. It specializes in integrating technologies related to wireless front-end, satellite communication, embedded systems, signal processing, network management, and software development. It offers wireless, Satcom products, wireless products, and software solutions from INSAT based mobile satellite services. Its wireless products include radar subsystems, radios, and radiofrequency subsystems. It caters to defense, railway, and marine industries.
Reasons for buying:
Buy PE was reasonable at 11.6 and above 10 years PE median of 10.88.
5-year earnings average is 10.45%, increasing steadily from 2012 and 10-Year average revenue growth is 8.98%.
Return on equity is good at 15.83% but the 5-year average is 16.92%.
The market cap of the company is ₹975.13cr.
The debt of the company is ₹179.14 cr with ₹163.61cr in cash.
Buy date: 29-Nov-2021
Qty: 10 Buy Price: ₹963.2 Buy EPS: 83 Buy PE: 11.6
I will not be adding if the price drops because the earnings average is 10% and the 5-year average isn't 20% and does not fit my rules. The stock is ok to own for now will sell when PE hits 30.
The company engaged in manufacturing and selling insoluble sulphur. The business activity of the group is operated through the segments of chemicals and general engineering products. It generates maximum revenue from the chemicals segment. The company offers products such as sulphuric acid, Oleum, and Diamond sulf, among others. Geographically, it derives a majority of revenue from export.
Reasons for buying:
Buy PE was reasonable at 5.72 and below 10 years PE median of 6.02. The shares are worth keeping for the long term.
10-year earnings average is 10% but lackluster and 10-Year average revenue growth is 6.03%.
Return on equity is ok at 12.26% but the 5-year average is 14.13%.
The market cap of the company is ₹6,403.25cr.
The debt of the company is ₹2.16 cr with ₹1,522.96 cr in cash. With that amount of cash, I will hold it for the long term.
Buy date: 26-Nov-2021
Qty: 25 Buy Price: ₹397.55 Buy EPS: 69.46 Buy PE: 5.72
I will stop buying when EPS drops to 19.87
Gujarat Narmada Valley Fertilizers & Chemicals Ltd is a firm engaged in the manufacturing and selling of fertilizers, industrial chemical products, and rendering information technology services. It operates in three business segments including Fertilizers, Chemicals, and Others. The company generates the majority of its revenues through the sale of chemicals.
Reasons for buying:
Buy PE was reasonable at 7.41 and below 10 years PE median of 8.78.
Earnings have increased 10 times since 2013 but lackluster and 10-Year average revenue growth is 13.02%.
Return on equity is excellent at 58.65% and the 5-year average is 32.11%.
The market cap of the company is ₹736.00cr.
The debt of the company is ₹40.46 cr with ₹123.77 cr in cash.
Buy date: 15-Nov-2021
Qty: 4 Buy Price: ₹2,131.5 Buy EPS: 287.44 Buy PE: 7.41
Q2 2021:
EPS was reduced by -33.08% to 192.36.
KSE Ltd is engaged in the manufacturing compound cattle feed. The company's operating segment includes Animal Feed; Oil cake processing and Dairy. It generates maximum revenue from the Animal Feed segment. The product line of the company consists of KS milk, KS curd, KS super, and KS supreme pellet.
Reasons for buying:
Buy PE was reasonable at 11.81 and below 10 years PE median of 18.12. The shares are worth keeping for the long term.
Earnings have increased 5 times since 2013 but lackluster and 10-Year average revenue growth is 16.18%.
Return on equity is excellent at 31.34% but the 5-year average is 22.57%.
The market cap of the company is ₹2,447.70cr.
The debt of the company is ₹18.74 cr with ₹212.29 cr in cash.
Buy date: 18-Aug-2021
Qty: 137 Buy Price: ₹72.65 Buy EPS: 6.15 Buy PE: 11.81
The price of the stock is down about -18.83% from my buy price.
The price has dropped 10% and has added 10k worth of shares. EPS is down -1.79% to 6.04.
Buy date: 25-Oct-2021
Qty: 153 Buy Price: ₹64.85 Buy EPS: 6.15 Buy PE: 10.54
The price has dropped another 10% and has added 10k worth of shares.
Buy date: 15-Nov-2021
Qty: 172 Buy Price: ₹58 Buy EPS: 6.04 Buy PE: 9.60
Marksans Pharma Ltd is a pharmaceutical company. It s engaged in the manufacturing and marketing of pharmaceutical formulations. It manufactures analgesics, expectorants, anti-diabetic, cardiovascular, central nervous system, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. The company also offers Contract Research and Manufacturing Services (CRAMS) to pharmaceutical companies. It has a global market presence with the majority of the revenue generated from North America, Europe, and the United Kingdom.
